Chronic stress and susceptibility to skin cancer

Journal of the National Cancer Institute

Volumn 97, Issue 23, 2005, Pages 1760-1767

  Saul, Alison N ^a   Oberyszyn, Tatiana M ^a   Daugherty, Christine ^a   Kusewitt, Donna ^a   Jones, Susie ^a   Jewell, Scott ^a   Malarkey, William B ^a   Lehman, Amy ^a   Lemeshow, Stanley ^a   Dhabhar, Firdaus S ^a,b  

^a OHIO STATE UNIVERSITY   (United States)

^b NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD3 ANTIGEN; CD4 ANTIGEN; CD8 ANTIGEN; CHEMOKINE; CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 12P40; INTERLEUKIN 2 RECEPTOR ALPHA; INTERLEUKIN 4; MESSENGER RNA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD ANALYSIS; CAGE; CANCER INCIDENCE; CANCER SUSCEPTIBILITY; CELL INFILTRATION; CELL PROTECTION; CONFIDENCE INTERVAL; CONTROLLED STUDY; FEMALE; FLOW CYTOMETRY; GENE EXPRESSION; IMMUNOHISTOCHEMISTRY; LEUKOCYTE; LONG TERM EXPOSURE; LYMPHOCYTE COUNT; LYMPHOCYTE HOMING; MOUSE; MOUSE STRAIN; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RADIATION EXPOSURE; REAL TIME POLYMERASE CHAIN REACTION; SKIN CANCER; SQUAMOUS CELL CARCINOMA; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; STRESS; SUPPRESSOR CELL; T LYMPHOCYTE; ULTRAVIOLET B RADIATION;

ANIMALS; ANTIGENS, CD3; CARCINOMA, SQUAMOUS CELL; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CHEMOKINES, CC; CHRONIC DISEASE; CYTOKINES; DISEASE MODELS, ANIMAL; DISEASE PROGRESSION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; IMMUNOHISTOCHEMISTRY; INTERFERON TYPE II; INTERLEUKIN-10; INTERLEUKIN-4; LEUKOCYTE COUNT; MICE; MICE, INBRED STRAINS; NEOPLASM REGRESSION, SPONTANEOUS; RECEPTORS, INTERLEUKIN-2; SKIN; SKIN NEOPLASMS; STRESS, PSYCHOLOGICAL; T-LYMPHOCYTES; TIME FACTORS; ULTRAVIOLET RAYS;

EID: 28944432430     PISSN: 00278874     EISSN: 14602105     Source Type: Journal    
DOI: 10.1093/jnci/dji401     Document Type: Article

References (53)

1. World Health Organization. Ultraviolet radiation. Available at: www.who.int/uv/en. [Last accessed: August 1, 2005.]
2. Ader R, Felten DL, Cohen N, editors. Psychoneuroimmunology. 3rd ed. San Diego (CA): Academic Press; 2001.
3. Dhabhar FS, McEwen BS. Acute stress enhances while chronic stress suppresses immune function in vivo: A potential role for leukocyte trafficking. Brain Behav Immun 1997; 11: 286-306.
4. Dhabhar FS, McEwen BS. Bidirectional effects of stress and glucocorticoid hormones on immune function: Possible explanations for paradoxical observations. In Ader R, Felten DL, Cohen N, editors. Psychoneuroimmunology. 3rd ed. San Diego (CA): Academic Press; 2001. p. 301-38.
5. Armstrong BK, Kricker A. The epidemiology of UV induced skin cancer. J Photochem Photobiol B 2001;63:8-18.
6. Berton TR, Pavone A, Fischer SM. Ultraviolet-B irradiation alters the cell cycle machinery in murine epidermis in vivo. J Invest Dermatol 2001;117:1171-8.
7. Morison WL, Parrish JA, Bloch KJ, Krugler JI. In-vivo effect of UV-B on lymphocyte function. Br J Dermatol 1979;101:513-19.
8. Kripke ML. Ultraviolet radiation and immunology: Something new under the sun - presidential address. Cancer Res 1994;54:6102-5.
9. Granstein RD, Matsui MS. UV radiation-induced immunosuppression and skin cancer. Cutis 2004;74:4-9.
10. Gloster HM, Brodland DG. The epidemiology of skin cancer. Dermatol Surg 1996;22:217-26.
11. Ortonne JP. From actinic keratosis to squamous cell carcinoma. Br J Dermatol 2002;146 Suppl 61:20-3.
12. van Kranen HJ, de Gruijl FR. Mutations in cancer genes of UV-induced skin tumors of hairless mice. J Epidemiol 1999;9(6 Suppl):S58-65.
13. de Gruijl FR, Forbes PD. UV-induced skin cancer in a hairless mouse model. Bioessays 1995;17:651-60.
14. Berkenbosch F, Wolvers DA, Derijk R. Neuroendocrine and immunological mechanisms in stress-induced immunomodulation. J Steroid Biochem Mol Biol 1991;40:639-47.
15. Glavin GB, Pare WP, Sandbak T, Bakke HK, Murison R. Restraint stress in biomedical research: An update. Neurosci Biobehav Rev 1994;18:223-49.
16. Kvetnansky R, Fukuhara K, Pacak K, Cizza G, Goldstein DS, Kopin IJ. Endogenous glucocorticoids restrain catecholamine synthesis and release at rest and during immobilization stress in rats. Endocrinology 1993;133:1411-9.
17. Dhabhar FS, Miller AH, McEwen BS, Spencer RI. Differential activation of adrenal steroid receptors in neural and immune tissues of Sprague Dawley, Fischer 344, and Lewis rats. J Neuroimmunol 1995;56:77-90.
18. Plotsky PM, Meaney MJ. Early, postnatal experience alters hypothalamic corticotropin-releasing factor (CRF) mRNA, median eminence CRF content and stress-induced release in adult rats. Brain Res Mol Brain Res 1993;18:195-200.
19. Kligman LH, Kligman AM. Histogenesis and progression in ultraviolet light-induced tumors in hairless mice. J Natl Cancer Inst 1981;67:1289-93.
20. Canfield PJ, Xu FN, Greenoak GE, Reeve VE, Gallagher CH, Wilkinson F. Ultrastructure of ultraviolet radiation-induced hairless mouse skin carcinogenesis, with special reference to the epidermal-dermal junction. Pathology 1986;18:337-44.
21. D'Agostini F, Fiallo P, DiMarco C, DeFlora S. Detection of p53 and histopathological classification of skin tumours induced by halogen lamps in hairless mice. Cancer Lett 1994;86:167-75.
22. Dhabhar FS, Satoskar AR, Bluethmann H, David JR, McEwen BS. Stress-induced enhancement of skin immune function: A role for gamma interferon. Proc Natl Acad Sci USA 2000;97:2846-51.
23. Curiel TJ, Coukos G, Zou L, Alvarez X, Cheng P, Mottram P, et al. Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival. Nat Med 2004;10:942-9.
24. + T cells in tumors from patients with early-stage non-small cell lung cancer and late-stage ovarian cancer. Cancer Res 2001;61:4766-72.
25. Ben-Eliyahu S, Yirmiya R, Liebeskind JC, Taylor AN, Gale RP. Stress increases metastatic spread of a mammary tumor in rats: Evidence for mediation by the immune system. Brain Behav Immun 1991;5:193-205.
26. Ben-Eliyahu S. The promotion of tumor metastasis by surgery and stress: immunological basis and implications for psychoneuroimmunology. Brain Behav Immun 2003;17 Suppl 1:S27-36.
27. Parker J, Klein SL, McClintock MK, Morison WJ, Ye X, Conti CJ, et al. Chronic stress accelerates ultraviolet-induced cutaneous carcinogenesis. J Am Acad Dermatol 2004;51:919-22.
28. Dhabhar FS, Miller AH, Stein M, McEwen BS, Spencer RL. Diurnal and stress-induced changes in distribution of peripheral blood leukocyte subpopulations. Brain Behav Immun 1994;8:66-79.
29. Sephton SE, Dhabhar FS, Classen C, Spiegel D. The diurnal cortisol slope as a predictor of immune reactivity to interpersonal stress [abstract]. Brain Behav Immun 2000;14:128.
30. Mormont MC, Levi F. Circadian-system alterations during cancer processes; a review. Int J Cancer 1997;70:241-7.
31. Filipski E, King VM, Li X, Granda TG, Mormont MC, Liu X, et al. Host circadian clock as a control point in tumor progression. J Natl Cancer Inst 2002;94:690-7.
32. Fu L, Lee CC. The circadian clock: Pacemaker and tumor suppressor. Nat Rev Cancer 2003;3:350-61.
33. Sephton SE, Sapolsky RM, Kraemer HC, Spiegel D. Early mortality in metastatic breast cancer patients with absent or abnormal diurnal cortisol rhythms. J Natl Cancer Inst 2000;92:994-1000.
34. Gatti G, Masera RG, Pallavicini L, Sartori ML, Staurenghi A, Orlandi F, et al. Interplay in vitro between ACTH, beta-endorphin, and glucocorticoids in the modulation of spontaneous and lymphokine-inducible human natural killer (NK) cell activity. Brain Behav Immun 1993;7:16-28.
35. Manetti R, Parronchi P, Giudizi MG, Piccini MP, Maggi E, Trinchieri G, et al. Natural killer cell stimulatory factor (interleukin 12 [IL-12]) induces T-helper type 1 (Th1)-specific immune responses and inhibits the development of IL-4-producing Th cells. J Exp Med 1993;177:1199-1204.
36. Shi X, Liu J, Xiang Z, Mitsuhashi M, Wu RS, Ma X. Gene expression analysis in interleukin-12-induced suppression of mouse mammary carcinoma. Int J Cancer 2004;110:570-8.
37. van Herpen CM, Looman M, Zonneveld M, Scharenborg N, de Wilde PC, van de Locht L, et al. Intratumoral administration of recombinant human interleukin-12 in head and neck squamous cell carcinoma patients elicits a T-helper 1 profile in the locoregional lymph nodes. Clin Cancer Res 2004;10:2626-35.
38. Kopp T, Kieffer JD, Rot A, Strommer S, Stingl G, Kupper TS. Inflammatory skin disease in K14/p40 transgenic mice: Evidence for interleukin-12-like activities of p40. J Invest Dermatol 2001;117:618-26.
39. Cooper AM, Kipnis A, Turner J, Magram J, Ferrante J, Orme IM. Mice lacking bioactive IL-12 can generate protective, antigen-specific cellular responses to mycobacterial infection only if the IL-12p40 subunit is present. J Immunol 2002;168:1322-7.
40. Oppmann B, Lesley R, Blom B, Timans JC, Xu Y, Hunte B, et al. Novel p19 protein engages IL-12p40 to form a cytokine, IL-23, with biological activities similar as well as distinct from IL-12. Immunity 2000;13:715-25.
41. Lankford CSR, Frucht DM. A unique role for IL-23 in promoting cellular immunity. J Leukoc Biol 2003;73:49-56.
42. Lo C-H, Lee S-C, Wu P-Y, Pan W-Y, Su J, Cheng C-W, et al. Anti-tumor and anti-metastatic activity of IL-23. J Immunol 2003;171:600-7.
43. Dighe AS, Richards E, Old LJ, Schreiber RD. Enhanced in vivo growth and resistance to rejection of tumor cells expressing dominant negative IFN gamma receptors. Immunity 1994;1:447-56.
44. Voest EE, Kenyon BM, O'Reilly MS, Truitt G, D'Amato RJ, Folkman J. Inhibition of angiogenesis in vivo by interleukin 12. J Natl Cancer Inst 1995;87:581-6.
45. Shankaran V, Ikeda H, Bruce AT, White JM, Swanson PE, Old LJ, et al. IFNγ and lymphocytes prevent primary tumour development and shape tumour immunogenicity. Nature 2001;410:1107-11.
46. Reiss Y, Proudfoot AE, Power CA, Campbell JJ, Butcher EC. CC chemokine receptor (CCR)4 and the CCR10 ligand cutaneous T cell-attracting chemokine (CTACK) in lymphocyte trafficking to inflamed skin. J Exp Med 2001;194:1541-7.
47. + T lymphocyte infiltration correlates with regression of a UV-induced squamous cell carcinoma. J Dermatol Sci 1995;9:12-9.
48. Romerdahl CA, Kripke ML. Role of helper T-lymphocytes in rejection of UV-induced murine skin cancers. Cancer Res 1988;48:2325-8.
49. + T cells. World J Surg 1995;19:352-8.
50. Greenberg PD. Adoptive T cell therapy of tumors: Mechanisms operative in the recognition and elimination of tumor cells. Adv Immunol 1991;49: 281-355.
51. Toes REM, Ossendorp F, Offringa R, Melief CJM. CD4 T cells and their role in anti-tumor immune responses. J Exp Med 1999;189:753-6.
52. Shevach EM. Regulatory T cells in autoimmunity. Annu Rev Immunol 2000;18:423-49.
53. Liyanage UK, Moore TT, Joo H, Tanaka Y, Herrmann V, Doherty G, et al. Prevalence of regulatory T cells in peripheral blood and tumor microenvironment of patients with pancreas or breast adenocarcinoma. J Immunol 2002;169:2756-61.